![]() | ||||||||
| Marsh McLennan 1166 Avenue of the Americas New York, New York 10036-2774 212 345 5000 www.marshmclennan.com | ||||||||
News release | |||||||||||
![]() | ||||||||
| Three Months Ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Revenue | $ | 7,061 | $ | 6,473 | ||||||||||
| Expense: | ||||||||||||||
| Compensation and benefits | 3,850 | 3,470 | ||||||||||||
| Other operating expenses | 1,206 | 1,078 | ||||||||||||
Operating expenses | 5,056 | 4,548 | ||||||||||||
| Operating income | 2,005 | 1,925 | ||||||||||||
| Other net benefit credits | 43 | 67 | ||||||||||||
| Interest income | 19 | 37 | ||||||||||||
| Interest expense | (245) | (159) | ||||||||||||
| Investment income | 5 | 1 | ||||||||||||
| Income before income taxes | 1,827 | 1,871 | ||||||||||||
| Income tax expense | 415 | 447 | ||||||||||||
| Net income before non-controlling interests | 1,412 | 1,424 | ||||||||||||
| Less: Net income attributable to non-controlling interests | 31 | 24 | ||||||||||||
| Net income attributable to the Company | $ | 1,381 | $ | 1,400 | ||||||||||
| Net income per share attributable to the Company: | ||||||||||||||
| - Basic | $ | 2.81 | $ | 2.84 | ||||||||||
| - Diluted | $ | 2.79 | $ | 2.82 | ||||||||||
| Average number of shares outstanding: | ||||||||||||||
| - Basic | 492 | 492 | ||||||||||||
| - Diluted | 495 | 497 | ||||||||||||
| Shares outstanding at March 31 | 493 | 493 | ||||||||||||
| Components of Revenue Change* | ||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | % Change GAAP Revenue* | Currency Impact | Acquisitions/ Dispositions/ Other Impact** | Non-GAAP Underlying Revenue | ||||||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||
| Risk and Insurance Services | ||||||||||||||||||||||||||||||||||||||
| Marsh (a) | $ | 3,453 | $ | 3,003 | 15 | % | (2) | % | 12 | % | 5 | % | ||||||||||||||||||||||||||
| Guy Carpenter | 1,206 | 1,148 | 5 | % | (1) | % | 1 | % | 5 | % | ||||||||||||||||||||||||||||
| Subtotal | 4,659 | 4,151 | 12 | % | (2) | % | 9 | % | 5 | % | ||||||||||||||||||||||||||||
| Fiduciary interest income | 103 | 122 | ||||||||||||||||||||||||||||||||||||
| Total Risk and Insurance Services | 4,762 | 4,273 | 11 | % | (2) | % | 9 | % | 4 | % | ||||||||||||||||||||||||||||
| Consulting | ||||||||||||||||||||||||||||||||||||||
| Mercer (b) | 1,496 | 1,425 | 5 | % | (2) | % | 3 | % | 4 | % | ||||||||||||||||||||||||||||
| Oliver Wyman Group | 818 | 789 | 4 | % | (1) | % | 1 | % | 4 | % | ||||||||||||||||||||||||||||
| Total Consulting | 2,314 | 2,214 | 5 | % | (2) | % | 2 | % | 4 | % | ||||||||||||||||||||||||||||
| Corporate Eliminations | (15) | (14) | ||||||||||||||||||||||||||||||||||||
| Total Revenue | $ | 7,061 | $ | 6,473 | 9 | % | (2) | % | 7 | % | 4 | % | ||||||||||||||||||||||||||
| Components of Revenue Change* | ||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | % Change GAAP Revenue* | Currency Impact | Acquisitions/ Dispositions/ Other Impact** | Non-GAAP Underlying Revenue | ||||||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||
| Marsh: | ||||||||||||||||||||||||||||||||||||||
| EMEA | $ | 1,059 | $ | 1,025 | 3 | % | (3) | % | — | 6 | % | |||||||||||||||||||||||||||
| Asia Pacific | 335 | 336 | — | (2) | % | (1) | % | 4 | % | |||||||||||||||||||||||||||||
| Latin America | 124 | 125 | (1) | % | (9) | % | — | 8 | % | |||||||||||||||||||||||||||||
| Total International | 1,518 | 1,486 | 2 | % | (3) | % | — | 6 | % | |||||||||||||||||||||||||||||
| U.S./Canada (a) | 1,935 | 1,517 | 28 | % | — | 24 | % | 4 | % | |||||||||||||||||||||||||||||
| Total Marsh | $ | 3,453 | $ | 3,003 | 15 | % | (2) | % | 12 | % | 5 | % | ||||||||||||||||||||||||||
| Mercer: | ||||||||||||||||||||||||||||||||||||||
| Wealth (b) | $ | 670 | $ | 672 | — | (2) | % | (1) | % | 3 | % | |||||||||||||||||||||||||||
| Health (b) | 608 | 538 | 13 | % | (2) | % | 8 | % | 7 | % | ||||||||||||||||||||||||||||
| Career | 218 | 215 | 2 | % | (2) | % | 5 | % | (1) | % | ||||||||||||||||||||||||||||
| Total Mercer | $ | 1,496 | $ | 1,425 | 5 | % | (2) | % | 3 | % | 4 | % | ||||||||||||||||||||||||||
(a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. (b)Acquisitions, dispositions and other in 2024 includes a net gain from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a gain in Wealth, offset by a loss in Health. | ||
* Rounded to whole percentages. Components of revenue may not add due to rounding. ** Acquisitions, dispositions and other includes the impact of current and prior year items excluded from the calculation of non-GAAP underlying revenue for comparability purposes. Details on these items are provided in the reconciliation of non-GAAP revenue to GAAP revenue tables included in this release. | ||
| Overview | ||
The Company reports its financial results in accordance with accounting principles generally accepted in the United States (referred to in this release as in accordance with "GAAP" or "reported" results). The Company also refers to and presents certain additional non-GAAP financial measures, within the meaning of Regulation G and item 10(e) Regulation S-K in accordance with the Securities Exchange Act of 1934. These measures are: non-GAAP revenue, adjusted operating income (loss), adjusted operating margin, adjusted income, net of tax and adjusted earnings per share (EPS). The Company has included reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP in the following tables. | ||
| The Company believes these non-GAAP financial measures provide useful supplemental information that enables investors to better compare the Company’s performance across periods. Management also uses these measures internally to assess the operating performance of its businesses and to decide how to allocate resources. However, investors should not consider these non-GAAP measures in isolation from, or as a substitute for, the financial information that the Company reports in accordance with GAAP. The Company's non-GAAP measures include adjustments that reflect how management views its businesses, and may differ from similarly titled non-GAAP measures presented by other companies. | ||
In the first quarter of 2025, the Company changed its methodology to report adjusted operating income (loss), adjusted income, net of tax and adjusted EPS to exclude the impact of intangible amortization and other net benefit credits. Prior year results are presented using the new methodology for comparative purposes. | ||
| Adjusted Operating Income (Loss) and Adjusted Operating Margin | ||
Adjusted operating income (loss) is calculated by excluding the impact of certain noteworthy items and identified intangible amortization expense from the Company's GAAP operating income (loss). The following tables reconcile adjusted operating income (loss) to GAAP operating income (loss) on a consolidated and reportable segment basis for the three months ended March 31, 2025 and 2024. The following tables also present adjusted operating margin. For the three months ended March 31, 2025 and 2024, adjusted operating margin is calculated by dividing the sum of adjusted operating income by consolidated or segment adjusted revenue. The Company's adjusted revenue used in the determination of adjusted operating margin is calculated by excluding the impact of certain noteworthy items from the Company's GAAP revenue. | ||
| Risk & Insurance Services | Consulting | Corporate/ Eliminations | Total | |||||||||||||||||||||||
Three Months Ended March 31, 2025 | ||||||||||||||||||||||||||
| Operating income (loss) | $ | 1,613 | $ | 456 | $ | (64) | $ | 2,005 | ||||||||||||||||||
| Operating margin | 33.9 | % | 19.7 | % | N/A | 28.4 | % | |||||||||||||||||||
| Add (deduct) impact of noteworthy items: | ||||||||||||||||||||||||||
| Restructuring (a) | 23 | 8 | 1 | 32 | ||||||||||||||||||||||
| Changes in fair value of contingent consideration | 3 | 6 | — | 9 | ||||||||||||||||||||||
| McGriff integration and retention related costs | 69 | — | — | 69 | ||||||||||||||||||||||
| Acquisition related costs | 7 | 2 | — | 9 | ||||||||||||||||||||||
| Gain on consolidation and disposal of business (b) | (28) | — | — | (28) | ||||||||||||||||||||||
| Total noteworthy items | 74 | 16 | 1 | 91 | ||||||||||||||||||||||
| Identified intangible amortization expense | 120 | 19 | — | 139 | ||||||||||||||||||||||
| Operating income adjustments | 194 | 35 | 1 | 230 | ||||||||||||||||||||||
| Adjusted operating income (loss) | $ | 1,807 | $ | 491 | $ | (63) | $ | 2,235 | ||||||||||||||||||
| Adjusted operating margin | 38.2 | % | 21.2 | % | N/A | 31.8 | % | |||||||||||||||||||
Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||
| Operating income (loss) | $ | 1,565 | $ | 432 | $ | (72) | $ | 1,925 | ||||||||||||||||||
| Operating margin | 36.6 | % | 19.5 | % | N/A | 29.7 | % | |||||||||||||||||||
| Add (deduct) impact of noteworthy items: | ||||||||||||||||||||||||||
| Restructuring | 22 | 11 | 9 | 42 | ||||||||||||||||||||||
| Changes in fair value of contingent consideration | 5 | 1 | — | 6 | ||||||||||||||||||||||
| Acquisition and disposition related costs (c) | 1 | 21 | — | 22 | ||||||||||||||||||||||
| Disposal of business (b) | — | (21) | — | (21) | ||||||||||||||||||||||
| Total noteworthy items | 28 | 12 | 9 | 49 | ||||||||||||||||||||||
| Identified intangible amortization expense | 79 | 11 | — | 90 | ||||||||||||||||||||||
| Operating income adjustments | 107 | 23 | 9 | 139 | ||||||||||||||||||||||
| Adjusted operating income (loss) | $ | 1,672 | $ | 455 | $ | (63) | $ | 2,064 | ||||||||||||||||||
| Adjusted operating margin | 39.1 | % | 20.7 | % | N/A | 32.0 | % | |||||||||||||||||||
(a)Costs in 2025 primarily include severance and lease exit charges for remaining restructuring activities. (b)Gain on sale of a business and a gain on remeasurement of an investment. In 2024, amount includes the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses. These amounts are included in revenue in the consolidated statements of income and excluded from non-GAAP revenue and adjusted revenue used in the calculation of adjusted operating margin. (c)Primarily reflects exit costs for the disposition of the Mercer U.K. pension administration and U.S. health and benefits administration businesses. | ||||||||||||||||||||||||||
Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||
| Amount | Adjusted EPS | Amount | Adjusted EPS | ||||||||||||||||||||||||||||||||
| Net income before non-controlling interests, as reported | $ | 1,412 | $ | 1,424 | |||||||||||||||||||||||||||||||
| Less: Non-controlling interest, net of tax | 31 | 24 | |||||||||||||||||||||||||||||||||
| Subtotal | $ | 1,381 | $ | 2.79 | $ | 1,400 | $ | 2.82 | |||||||||||||||||||||||||||
| Operating income adjustments | $ | 230 | $ | 139 | |||||||||||||||||||||||||||||||
| Other net benefit credits | (43) | (67) | |||||||||||||||||||||||||||||||||
| Investments adjustment | (2) | (1) | |||||||||||||||||||||||||||||||||
Income tax effect of adjustments (a) | (50) | (18) | |||||||||||||||||||||||||||||||||
| 135 | 0.27 | 53 | 0.10 | ||||||||||||||||||||||||||||||||
| Adjusted income, net of tax | $ | 1,516 | $ | 3.06 | $ | 1,453 | $ | 2.92 | |||||||||||||||||||||||||||
(a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | |||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Consolidated | ||||||||||||||
| Compensation and benefits | $ | 3,850 | $ | 3,470 | ||||||||||
| Other operating expenses | 1,206 | 1,078 | ||||||||||||
| Total expenses | $ | 5,056 | $ | 4,548 | ||||||||||
| Depreciation and amortization expense | $ | 88 | $ | 99 | ||||||||||
| Identified intangible amortization expense | 139 | 90 | ||||||||||||
| Total | $ | 227 | $ | 189 | ||||||||||
| Risk and Insurance Services | ||||||||||||||
Compensation and benefits | $ | 2,451 | $ | 2,118 | ||||||||||
Other operating expenses | 698 | 590 | ||||||||||||
| Total expenses | $ | 3,149 | $ | 2,708 | ||||||||||
| Depreciation and amortization expense | $ | 50 | $ | 46 | ||||||||||
| Identified intangible amortization expense | 120 | 79 | ||||||||||||
| Total | $ | 170 | $ | 125 | ||||||||||
| Consulting | ||||||||||||||
Compensation and benefits | $ | 1,363 | $ | 1,314 | ||||||||||
Other operating expenses | 495 | 468 | ||||||||||||
| Total expenses | $ | 1,858 | $ | 1,782 | ||||||||||
| Depreciation and amortization expense | $ | 24 | $ | 37 | ||||||||||
| Identified intangible amortization expense | 19 | 11 | ||||||||||||
| Total | $ | 43 | $ | 48 | ||||||||||
| (Unaudited) March 31, 2025 | December 31, 2024 | |||||||||||||
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | 1,604 | $ | 2,398 | ||||||||||
| Cash and cash equivalents held in a fiduciary capacity | 11,579 | 11,276 | ||||||||||||
| Net receivables | 7,872 | 7,156 | ||||||||||||
| Other current assets | 1,406 | 1,287 | ||||||||||||
| Total current assets | 22,461 | 22,117 | ||||||||||||
| Goodwill and intangible assets | 28,274 | 28,126 | ||||||||||||
| Fixed assets, net | 840 | 859 | ||||||||||||
| Pension related assets | 2,021 | 1,914 | ||||||||||||
| Right of use assets | 1,477 | 1,498 | ||||||||||||
| Deferred tax assets | 250 | 237 | ||||||||||||
| Other assets | 1,692 | 1,730 | ||||||||||||
| TOTAL ASSETS | $ | 57,015 | $ | 56,481 | ||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Short-term debt | $ | 1,667 | $ | 519 | ||||||||||
| Accounts payable and accrued liabilities | 3,450 | 3,402 | ||||||||||||
| Accrued compensation and employee benefits | 1,798 | 3,620 | ||||||||||||
| Current lease liabilities | 327 | 325 | ||||||||||||
| Accrued income taxes | 554 | 376 | ||||||||||||
| Dividends payable | 400 | — | ||||||||||||
| Fiduciary liabilities | 11,579 | 11,276 | ||||||||||||
| Total current liabilities | 19,775 | 19,518 | ||||||||||||
| Long-term debt | 18,862 | 19,428 | ||||||||||||
| Pension, post-retirement and post-employment benefits | 832 | 840 | ||||||||||||
| Long-term lease liabilities | 1,563 | 1,590 | ||||||||||||
| Liabilities for errors and omissions | 309 | 305 | ||||||||||||
| Other liabilities | 1,406 | 1,265 | ||||||||||||
| Total equity | 14,268 | 13,535 | ||||||||||||
| TOTAL LIABILITIES AND EQUITY | $ | 57,015 | $ | 56,481 | ||||||||||
| Three Months Ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Operating cash flows: | ||||||||||||||
| Net income before non-controlling interests | $ | 1,412 | $ | 1,424 | ||||||||||
| Adjustments to reconcile net income to cash provided by operations: | ||||||||||||||
| Depreciation and amortization | 227 | 189 | ||||||||||||
| Non-cash lease expense | 73 | 67 | ||||||||||||
| Share-based compensation expense | 112 | 103 | ||||||||||||
| Net (gain) on investments, disposition of assets and other | (39) | (28) | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Accrued compensation and employee benefits | (1,858) | (1,779) | ||||||||||||
| Provision for taxes, net of payments and refunds | 178 | 209 | ||||||||||||
| Net receivables | (599) | (742) | ||||||||||||
| Other changes to assets and liabilities | 9 | (59) | ||||||||||||
| Contributions to pension and other benefit plans in excess of current year credit | (55) | (88) | ||||||||||||
| Operating lease liabilities | (82) | (77) | ||||||||||||
| Net cash used by operations | (622) | (781) | ||||||||||||
| Financing cash flows: | ||||||||||||||
| Purchase of treasury shares | (300) | (300) | ||||||||||||
| Net proceeds from issuance of commercial paper | 1,048 | 50 | ||||||||||||
| Proceeds from issuance of debt | — | 989 | ||||||||||||
| Repayments of debt | (505) | (1,004) | ||||||||||||
| Net issuance of common stock from treasury shares | (9) | (56) | ||||||||||||
| Net distributions of non-controlling interests and deferred/contingent consideration | (53) | (19) | ||||||||||||
| Dividends paid | (405) | (354) | ||||||||||||
| Change in fiduciary liabilities | 86 | 829 | ||||||||||||
| Net cash (used for) provided by financing activities | (138) | 135 | ||||||||||||
| Investing cash flows: | ||||||||||||||
| Capital expenditures | (55) | (87) | ||||||||||||
| Purchases of long-term investments and other | (10) | (10) | ||||||||||||
| Sales of long-term investments | 84 | 4 | ||||||||||||
| Dispositions | 25 | 26 | ||||||||||||
| Acquisitions, net of cash and cash held in a fiduciary capacity acquired | (18) | (301) | ||||||||||||
| Net cash provided by (used for) investing activities | 26 | (368) | ||||||||||||
| Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | 243 | (228) | ||||||||||||
| (Decrease) in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | (491) | (1,242) | ||||||||||||
| Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period | 13,674 | 14,152 | ||||||||||||
| Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period | $ | 13,183 | $ | 12,910 | ||||||||||
| Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets | ||||||||||||||
Balance at March 31, | 2025 | 2024 | ||||||||||||
| (In millions) | ||||||||||||||
| Cash and cash equivalents | $ | 1,604 | $ | 1,452 | ||||||||||
| Cash and cash equivalents held in a fiduciary capacity | 11,579 | 11,458 | ||||||||||||
| Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | 13,183 | $ | 12,910 | ||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | GAAP Revenue | Currency Impact | Acquisitions/ Dispositions/ Other Impact | Non-GAAP Revenue | GAAP Revenue | Acquisitions/ Dispositions/ Other Impact | Non-GAAP Revenue | |||||||||||||||||||||||||||||||||||||
| Risk and Insurance Services | ||||||||||||||||||||||||||||||||||||||||||||
| Marsh (a) | $ | 3,453 | $ | 53 | $ | (365) | $ | 3,141 | $ | 3,003 | $ | (8) | $ | 2,995 | ||||||||||||||||||||||||||||||
| Guy Carpenter | 1,206 | 13 | (15) | 1,204 | 1,148 | — | 1,148 | |||||||||||||||||||||||||||||||||||||
| Subtotal | 4,659 | 66 | (380) | 4,345 | 4,151 | (8) | 4,143 | |||||||||||||||||||||||||||||||||||||
| Fiduciary interest income | 103 | 1 | (5) | 99 | 122 | — | 122 | |||||||||||||||||||||||||||||||||||||
| Total Risk and Insurance Services | 4,762 | 67 | (385) | 4,444 | 4,273 | (8) | 4,265 | |||||||||||||||||||||||||||||||||||||
| Consulting | ||||||||||||||||||||||||||||||||||||||||||||
| Mercer (b) | 1,496 | 32 | (70) | 1,458 | 1,425 | (22) | 1,403 | |||||||||||||||||||||||||||||||||||||
| Oliver Wyman Group | 818 | 8 | (9) | 817 | 789 | (4) | 785 | |||||||||||||||||||||||||||||||||||||
| Total Consulting | 2,314 | 40 | (79) | 2,275 | 2,214 | (26) | 2,188 | |||||||||||||||||||||||||||||||||||||
| Corporate Eliminations | (15) | — | — | (15) | (14) | — | (14) | |||||||||||||||||||||||||||||||||||||
| Total Revenue | $ | 7,061 | $ | 107 | $ | (464) | $ | 6,704 | $ | 6,473 | $ | (34) | $ | 6,439 | ||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | GAAP Revenue | Currency Impact | Acquisitions/ Dispositions/ Other Impact | Non-GAAP Revenue | GAAP Revenue | Acquisitions/ Dispositions/ Other Impact | Non-GAAP Revenue | |||||||||||||||||||||||||||||||||||||
| Marsh: | ||||||||||||||||||||||||||||||||||||||||||||
| EMEA | $ | 1,059 | $ | 28 | $ | 2 | $ | 1,089 | $ | 1,025 | $ | (1) | $ | 1,024 | ||||||||||||||||||||||||||||||
| Asia Pacific | 335 | 8 | — | 343 | 336 | (4) | 332 | |||||||||||||||||||||||||||||||||||||
| Latin America | 124 | 11 | — | 135 | 125 | — | 125 | |||||||||||||||||||||||||||||||||||||
| Total International | 1,518 | 47 | 2 | 1,567 | 1,486 | (5) | 1,481 | |||||||||||||||||||||||||||||||||||||
| U.S./Canada (a) | 1,935 | 6 | (367) | 1,574 | 1,517 | (3) | 1,514 | |||||||||||||||||||||||||||||||||||||
| Total Marsh | $ | 3,453 | $ | 53 | $ | (365) | $ | 3,141 | $ | 3,003 | $ | (8) | $ | 2,995 | ||||||||||||||||||||||||||||||
| Mercer: | ||||||||||||||||||||||||||||||||||||||||||||
| Wealth (b) | $ | 670 | $ | 15 | $ | (60) | $ | 625 | $ | 672 | $ | (66) | $ | 606 | ||||||||||||||||||||||||||||||
| Health (b) | 608 | 12 | — | 620 | 538 | 44 | 582 | |||||||||||||||||||||||||||||||||||||
| Career | 218 | 5 | (10) | 213 | 215 | — | 215 | |||||||||||||||||||||||||||||||||||||
| Total Mercer | $ | 1,496 | $ | 32 | $ | (70) | $ | 1,458 | $ | 1,425 | $ | (22) | $ | 1,403 | ||||||||||||||||||||||||||||||
(a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. (b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | ||||||||||||||||||||||||||||||||||||||||||||
Note: Amounts in the tables above are rounded to whole numbers. | ||||||||||||||||||||||||||||||||||||||||||||